Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rank in Stocks #38575
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Share Price
$1.48
Market Cap
$883.58K
Change (1 day)
-1.99%
Change (1 year)
-88.89%
Country
US
Trade Enveric Biosciences, Inc. (ENVB)

Category

Dividend yield history for Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (stock symbol: ENVB) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Enveric Biosciences, Inc. (ENVB) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors